Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -213.25 is 68% below its 4-year average of -127.10, around the middle of its 4-year range (-357.13–-31.99).
8.11% above its 12-month average of -232.07.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -151.80.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
EARNINGS PER SHARE (EPS)
-213.25
EARNINGS PER SHARE (EPS) AVG TTM
-232.07
EARNINGS PER SHARE (EPS) AVG 3Y
-150.88
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.11%
CURRENT VS 3Y AVG
-41.34%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Profusa, Inc. Common Stock
Market Cap
$1.86M
Earnings Per Share (EPS)
-213.25
TTM Avg
-232.07
3Y Avg
-150.88
5Y Avg
N/A
Market Cap
$1.83M
Earnings Per Share (EPS)
-50.69
TTM Avg
-49.87
3Y Avg
-19185.19
5Y Avg
-12947.08
Market Cap
$1.89M
Earnings Per Share (EPS)
-46.30
TTM Avg
-226.80
3Y Avg
-2352.88
5Y Avg
-5539.80
Market Cap
$1.89M
Earnings Per Share (EPS)
-46.49
TTM Avg
-92.15
3Y Avg
-143.14
5Y Avg
-171.91
Market Cap
$1.93M
Earnings Per Share (EPS)
-53.60
TTM Avg
-139.70
3Y Avg
-437.70
5Y Avg
-488.64
Market Cap
$1.80M
Earnings Per Share (EPS)
-1.95
TTM Avg
-2.56
3Y Avg
-13.27
5Y Avg
-27.21
Market Cap
$1.65M
Earnings Per Share (EPS)
-5.35
TTM Avg
-12.67
3Y Avg
-17.25
5Y Avg
-14.07
Market Cap
$2.11M
Earnings Per Share (EPS)
-13.89
TTM Avg
-71.45
3Y Avg
-134.10
5Y Avg
-124.65
Market Cap
$2.14M
Earnings Per Share (EPS)
-2.06
TTM Avg
-2.14
3Y Avg
-10.33
5Y Avg
-14.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.86M | -213.25 | -232.07 | -150.88 | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.83M | -50.69 | -49.87 | -19185.19 | -12947.08 |
| Tenon Medical, Inc. (TNON)vs › | $1.89M | -46.30 | -226.80 | -2352.88 | -5539.80 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.89M | -46.49 | -92.15 | -143.14 | -171.91 |
| Beyond Air, Inc. (XAIR)vs › | $1.93M | -53.60 | -139.70 | -437.70 | -488.64 |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.80M | -1.95 | -2.56 | -13.27 | -27.21 |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | -5.35 | -12.67 | -17.25 | -14.07 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.11M | -13.89 | -71.45 | -134.10 | -124.65 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | -2.06 | -2.14 | -10.33 | -14.99 |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.51M | -10.02 | -4.85 | -7.18 | -7.18 |
Trailing EPS (TTM)
$-213.25
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -107.01 |
| 2024-12-31 | -357.13 |
| 2023-12-31 | -76.65 |
| 2022-12-31 | -62.74 |
| 2021-12-31 | -31.99 |
